NASDAQ:PRVB - Provention Bio Price Target & Analyst Ratings

$10.80
-0.56 (-4.93 %)
(As of 06/19/2019 03:17 AM ET)
Today's Range
$10.51
Now: $10.80
$11.98
50-Day Range
$3.12
MA: $5.35
$14.14
52-Week Range
$1.52
Now: $10.80
$22.82
Volume824,554 shs
Average Volume419,842 shs
Market Capitalization$403.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Provention Bio (NASDAQ:PRVB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Provention Bio in the last 12 months. Their average twelve-month price target is $11.3333, suggesting that the stock has a possible upside of 4.94%. The high price target for PRVB is $20.00 and the low price target for PRVB is $6.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.3333$7.00$7.00N/A
Price Target Upside: 4.94% upside108.33% upside191.67% upsideN/A

Provention Bio (NASDAQ:PRVB) Consensus Price Target History

Price Target History for Provention Bio (NASDAQ:PRVB)

Provention Bio (NASDAQ:PRVB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/10/2019Chardan CapitalInitiated CoverageBuy$20.00HighView Rating Details
5/28/2019HC WainwrightSet Price TargetBuy$8.00MediumView Rating Details
2/22/2019Leerink SwannInitiated CoverageOutperformLowView Rating Details
2/22/2019Svb LeerinkInitiated CoverageOutperform$6.00LowView Rating Details
(Data available from 6/19/2017 forward)
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel